BMJ - Why blood testing companies need effective regulation (26 October 2022)

Summary

In the UK, regulation prevents prescription-only medications being advertised directly to consumers, but not medical tests. This opinion piece in the BMJ raises concerns about the growing availability and popularity of consumer blood testing. The authors found that dozens of companies are offering health screening for a range of conditions and deficiencies through blood testing kits for use at home. They are often advertised to people with symptoms such as tiredness, low energy, irritability, sleep problems and weight issues.

The authors highlight that reading blood test results requires context and training, and results can give people a false sense of security or panic depending on whether they are perceived to be in 'normal' range. They call for guidance on mixing NHS and private care to be updated and recommend that the Care Quality Commission (CQC) should be empowered to appraise private screening and the apps that recommend it.